These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 31775909)
1. IL-17 inhibits CXCL9/10-mediated recruitment of CD8 Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909 [TBL] [Abstract][Full Text] [Related]
2. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10. Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349 [TBL] [Abstract][Full Text] [Related]
3. Th17 cells inhibit CD8 Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584 [TBL] [Abstract][Full Text] [Related]
4. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303 [TBL] [Abstract][Full Text] [Related]
5. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Karin N Front Immunol; 2020; 11():976. PubMed ID: 32547545 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8 Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors. Liu R; Lu Z; Gu J; Liu J; Huang E; Liu X; Wang L; Yang J; Deng Y; Qian J; Luo F; Wang Z; Zhang H; Jiang X; Zhang D; Qian J; Liu G; Zhu H; Qian Y; Liu Z; Chu Y Gastroenterology; 2018 Feb; 154(3):637-651.e7. PubMed ID: 29031499 [TBL] [Abstract][Full Text] [Related]
8. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression. Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856 [TBL] [Abstract][Full Text] [Related]
9. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors. Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875 [TBL] [Abstract][Full Text] [Related]
10. LINC00152 mediates CD8 Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190 [TBL] [Abstract][Full Text] [Related]
11. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767 [TBL] [Abstract][Full Text] [Related]
12. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141 [TBL] [Abstract][Full Text] [Related]
13. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. Zumwalt TJ; Arnold M; Goel A; Boland CR Oncotarget; 2015 Feb; 6(5):2981-91. PubMed ID: 25671296 [TBL] [Abstract][Full Text] [Related]
14. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212 [TBL] [Abstract][Full Text] [Related]
15. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098 [TBL] [Abstract][Full Text] [Related]
16. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Yang H; Yamazaki T; Pietrocola F; Zhou H; Zitvogel L; Ma Y; Kroemer G Cancer Res; 2015 Sep; 75(18):3812-22. PubMed ID: 26208907 [TBL] [Abstract][Full Text] [Related]
17. Gut microbiota modulate T cell trafficking into human colorectal cancer. Cremonesi E; Governa V; Garzon JFG; Mele V; Amicarella F; Muraro MG; Trella E; Galati-Fournier V; Oertli D; Däster SR; Droeser RA; Weixler B; Bolli M; Rosso R; Nitsche U; Khanna N; Egli A; Keck S; Slotta-Huspenina J; Terracciano LM; Zajac P; Spagnoli GC; Eppenberger-Castori S; Janssen KP; Borsig L; Iezzi G Gut; 2018 Nov; 67(11):1984-1994. PubMed ID: 29437871 [TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC Akeus P; Szeponik L; Ahlmanner F; Sundström P; Alsén S; Gustavsson B; Sparwasser T; Raghavan S; Quiding-Järbrink M Cancer Immunol Immunother; 2018 Jul; 67(7):1067-1077. PubMed ID: 29671006 [TBL] [Abstract][Full Text] [Related]
19. m Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498 [TBL] [Abstract][Full Text] [Related]